These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11711289)

  • 21. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly active antimycobacterial derivatives of benzoxazine.
    Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
    Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of oligosaccharides as potential inhibitors of mycobacterial arabinosyltransferases. Di- and trisaccharides containing C-5 modified arabinofuranosyl residues.
    Cociorva OM; Lowary TL
    Carbohydr Res; 2004 Mar; 339(4):853-65. PubMed ID: 14980829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disaccharide analogs as probes for glycosyltransferases in Mycobacterium tuberculosis.
    Pathak AK; Pathak V; Seitz L; Gurcha SS; Besra GS; Riordan JM; Reynolds RC
    Bioorg Med Chem; 2007 Aug; 15(16):5629-50. PubMed ID: 17544276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol.
    Belanger AE; Besra GS; Ford ME; Mikusová K; Belisle JT; Brennan PJ; Inamine JM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11919-24. PubMed ID: 8876238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oriented development of antituberculotics: salicylanilides.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
    Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
    Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New S-benzylisothiosemicarbazones with antimycobacterial activity.
    Petrlíková E; Waisser K; Heinisch L; Stolaříková J
    Folia Microbiol (Praha); 2011 Jan; 56(1):10-2. PubMed ID: 21394476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconstitution of functional mycobacterial arabinosyltransferase AftC proteoliposome and assessment of decaprenylphosphorylarabinose analogues as arabinofuranosyl donors.
    Zhang J; Angala SK; Pramanik PK; Li K; Crick DC; Liav A; Jozwiak A; Swiezewska E; Jackson M; Chatterjee D
    ACS Chem Biol; 2011 Aug; 6(8):819-28. PubMed ID: 21595486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
    Copp BR; Christiansen HC; Lindsay BS; G Franzblau S
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4097-9. PubMed ID: 16005211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of octyl arabinofuranosides as substrates for mycobacterial arabinosyltransferases.
    Han J; Gadikota RR; McCarren PR; Lowary TL
    Carbohydr Res; 2003 Mar; 338(7):581-8. PubMed ID: 12644370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a specific arabinosyltransferase activity involved in mycobacterial arabinan biosynthesis.
    Khasnobis S; Zhang J; Angala SK; Amin AG; McNeil MR; Crick DC; Chatterjee D
    Chem Biol; 2006 Jul; 13(7):787-95. PubMed ID: 16873027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
    Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
    Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of l-asparaginase as a potential metabolic target against Mycobacterium tuberculosis.
    Kataria A; Singh J; Kundu B
    J Cell Biochem; 2019 Jan; 120(1):143-154. PubMed ID: 30230585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.
    Carta A; Bua A; Corona P; Piras S; Briguglio I; Molicotti P; Zanetti S; Laurini E; Aulic S; Fermeglia M; Pricl S
    Eur J Med Chem; 2019 Jan; 161():399-415. PubMed ID: 30384044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.
    Sriram D; Aubry A; Yogeeswari P; Fisher LM
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.